ISDA AGM: BlackRock’s Kim Outlines Regulatory Drawbacks For Buyside

Regulatory proposals covering over-the-counter derivatives will bring significant costs to end users, while rules surrounding reporting requirements and collateral remain unclear and need further clarification, according to Joel Kim, head of fixed income, Asia Pacific, at BlackRock.

  • 24 Apr 2013

Regulatory proposals covering over-the-counter derivatives will bring significant costs to end users, while rules surrounding reporting requirements and collateral remain unclear and need further clarification, according to Joel Kim, head of fixed income, Asia Pacific, at BlackRock.

“From a buyside perspective, such as things like reporting requirements, yes ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 164,197.28 637 7.95%
2 JPMorgan 154,023.20 666 7.46%
3 Bank of America Merrill Lynch 148,673.66 492 7.20%
4 Barclays 126,568.82 444 6.13%
5 HSBC 110,180.81 519 5.34%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 25,941.92 30 9.52%
2 Citi 16,837.08 38 6.18%
3 SG Corporate & Investment Banking 15,661.30 47 5.75%
4 Deutsche Bank 14,193.64 44 5.21%
5 Bank of America Merrill Lynch 13,028.84 31 4.78%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Goldman Sachs 6,961.44 31 9.19%
2 JPMorgan 6,815.38 29 8.99%
3 UBS 5,503.59 15 7.26%
4 Citi 5,145.98 30 6.79%
5 Deutsche Bank 4,303.27 25 5.68%